Projects per year
Personal profile
Education
- 2011 Dphil Clinical Pharmacology Department, University of Oxford
- 2005 M.S., Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2003 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2020- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2020- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2019- Director, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2017-2020 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2017-2020 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014-2017 Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2013-2017 Assistant Professor, Department of Clinical Pharmacy, Taipei Medical University
Research Interests
- Molecular mechanisms of tumorigenesis and translational medicine
- Toxicology and development of nanomaterials as drug delivery platform
- Protein post-translational modifications in cancer regulation
Fingerprint
Dive into the research topics where Er-Chieh Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 13 Finished
-
探討粒線體因子C20orf7在大腸癌進程中對化療藥物抗藥性及上皮細胞間質轉化作用EMT之調控機轉及大腸癌合併治療策略研究
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討趨化因子CCR6於大腸癌5-FU抗藥性的調控機轉及合併治療研究
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
官能性奈米鑽石複合金屬氧化物於對抗自由基及抗老化之應用性研究
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
-
Deciphering the Molecular Regulatory Mechanisms of Ccl20-Ccr6 Chemokine Cascade in Epithelial-Mesenchymal Transition and Chemo-Resistance in Colon Cancer, and Also the Strategy for Cancer Treatment
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
以粒線體因子NDUFAF5為標的來抑制 5FU抗藥性大腸癌之聯合治療探討及調控機轉分析
7/1/19 → 2/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Co2+-Doped BiOBrxCl1-x hierarchical microspheres display enhanced visible-light photocatalytic performance in the degradation of rhodamine B and antibiotics and the inactivation of E. coli
Cho, E. C., Chang-Jian, C. W., Huang, J. H., Lee, G. Y., Hung, W. H., Sung, M. Y., Lee, K. C., Weng, H. C., Syu, W. L., Hsiao, Y. S. & Chen, C. P., Jan 15 2021, In: Journal of Hazardous Materials. 402, 123457.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Laser scribing of Ag-decorated graphene for high-performance and flexible heaters
Cho, E. C., Chang-Jian, C. W., Huang, J. H., Wu, R. T., Lu, C. Z., Lee, K. C., Weng, H. C. & Hsu, S. C., 2021, (Accepted/In press) In: Journal of the Taiwan Institute of Chemical Engineers.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Co2+-Doped BiOBrxCl1-x hierarchical microspheres display enhanced visible-light photocatalytic performance in the degradation of rhodamine B and antibiotics and the inactivation of E. coli
Cho, E-C., Chang-Jian, C-W., Huang, J-H., Lee, G-Y., Hung, W-H., Sung, M-Y., Lee, K-C., Weng, H. C., Syu, W-L., Hsiao, Y-S. & Chen, C-P., 2020, In: Journal of Hazardous Materials. 402, p. 123457 1 p.Research output: Contribution to journal › Article › peer-review
-
Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer
Chen, C. H., Hsieh, Y. C., Yang, P. M., Liu, Y. R. & Cho, E. C., 2020, In: Biochemical and Biophysical Research Communications.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
GFP Plasmid and Chemoreagent Conjugated with Graphene Quantum Dots as a Novel Gene Delivery Platform for Colon Cancer Inhibition in Vitro and in Vivo
Lo, P. Y., Lee, G. Y., Zheng, J. H., Huang, J. H., Cho, E. C. & Lee, K. C., Sep 21 2020, In: ACS Applied Bio Materials. 3, 9, p. 5948-5956 9 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)